Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 63 holding rows worth $291,456,000.

Accession
0001214659-18-007149
Filed
2018-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 64 entries on the cover page, a total value of $291,456,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $291,456,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR363,960$14,620,000thousands by filing date
CIGNA CORPORATION125509109COM67,449$14,046,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock281,100$13,816,000thousands by filing dateput
KURA ONCOLOGY INC COM50127T109Stock727,258$12,727,000thousands by filing date
AETNA INC NEW00817Y108COM60,444$12,261,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR266,388$11,900,000thousands by filing date
HCA Healthcare Inc40412C101COM83,822$11,661,000thousands by filing date
Amgen Inc.031162100COM50,000$10,365,000thousands by filing dateput
MEI PHARMA INC55279B202COM NEW2,303,645$9,929,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock104,176$9,117,000thousands by filing date
BIONANO GENOMICS INC09075F107COM1,440,857$7,353,000thousands by filing date
UROVANT SCIENCESG9381B108COMMON STOCK591,454$7,097,000thousands by filing date
BIOGEN INC COM09062X103Stock19,300$6,819,000thousands by filing date
Elevance Health, Inc.036752103COM24,803$6,797,000thousands by filing date
HUMANA INC COM444859102Stock20,054$6,789,000thousands by filing date
PREMIER INC74051N102CL A144,412$6,611,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM170,000$6,416,000thousands by filing dateput
Merck & Co.,Inc.58933Y105COM84,000$5,959,000thousands by filing datecall
CATALYST BIOSCIENCES INC14888D208COM550,977$5,940,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,843,501$5,918,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock41,393$5,292,000thousands by filing date
SMITH & NEPHEW PLC SPDN ADR NEW83175M205ADR134,388$4,984,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR57,691$4,971,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM226,200$4,524,000thousands by filing dateput
FOAMIX PHARMACEUTICALS LTDM46135105SHS770,000$4,412,000thousands by filing date
KONINKLIJKE PHILIPS N V NY REGIS SHS NEW500472303ADR95,776$4,359,000thousands by filing date
Amgen Inc.031162100COM20,000$4,146,000thousands by filing datecall
REVANCE THERAPEUTICS INC761330109COM164,353$4,084,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM213,252$3,715,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM25,785$3,584,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock23,198$3,567,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM232,539$3,488,000thousands by filing date
Medtronic PlcG5960L103COM35,196$3,462,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR87,400$3,458,000thousands by filing dateput
CARDINAL HEALTH INC14149Y108COM62,004$3,348,000thousands by filing date
UnitedHealth Group Inc91324P102COM12,579$3,347,000thousands by filing date
ALLERGAN PLCG0177J108SHS17,500$3,333,000thousands by filing dateput
Pfizer Inc.717081103COM71,500$3,151,000thousands by filing dateput
EMERGENT BIOSOLUTIONS INC29089Q105COM41,799$2,752,000thousands by filing date
NEVRO CORP64157F103COM45,091$2,570,000thousands by filing date
RA MED SYS INC74933X104COM135,553$2,467,000thousands by filing date
AFFIMED N VN01045108COM557,615$2,426,000thousands by filing date
HILL ROM HLDGS INC431475102COM24,036$2,269,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM114,259$2,190,000thousands by filing date
CONFORMIS INC20717E101COM1,861,789$1,973,000thousands by filing date
SENSEONICS HLDGS INC81727U105COM402,408$1,919,000thousands by filing date
VICAL INC925602203COM NEW1,239,813$1,699,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value164,943$1,559,000thousands by filing date
AKCEA THERAPEUTICS INC00972L107COM43,300$1,516,000thousands by filing dateput
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK32,832$1,505,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock416,458$1,437,000thousands by filing date
ELECTROCORE INC28531P103COM86,120$1,206,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM70,712$1,188,000thousands by filing date
PFENEX INC717071104COM213,608$1,092,000thousands by filing date
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK44,678$1,077,000thousands by filing date
Abbott Laboratories002824100COM14,220$1,043,000thousands by filing date
TITAN MED INC88830X819COM445,680$949,000thousands by filing date
ACHIEVE LIFE SCIENCE INC004468203COM NEW165,982$523,000thousands by filing date
OPTINOSE INC68404V100COM27,068$336,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK21,600$230,000thousands by filing dateput
GTX INC DEL40052B207COM NEW51,500$81,000thousands by filing dateput
VITAL THERAPIES INC92847R104COM194,700$54,000thousands by filing dateput
VITAL THERAPIES INC92847R104COM103,707$29,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-18-007149this filing2018-11-14acceptance time not in the bulk data set